Pharma’s Next Supply Chain Revolution
The article explores how geopolitical shifts, ESG priorities, digital transformation, and localization policies are reshaping pharmaceutical supply chains, manufacturing strategies, operational resilience, and competitive dynamics across the global healthcare industry.
Q1. Could you start by giving us a brief overview of your professional background, particularly focusing on your expertise in the industry?
Seasoned leader with vast experience in general global pharma management, managing complicated operational networks and global supply chains. Global complicated supply chain strategy refresh and AI-based digitalization
Proven capabilities in the implementation of turnaround plans to switch the business into profitability. Profound understanding of business processes and information systems, and experience in implementation—creation of a robust and effective metrics system for organizational learning. Strive for constant improvement through operational excellence (OPEX).
Q2. How are global pharmaceutical supply chains evolving in response to geopolitical uncertainty, regulatory pressure, and changing healthcare demand patterns?
Deglobalization, Digital and AI integration, and reducing cycle time.
Q3. How are sustainability and ESG priorities influencing manufacturing, packaging, and logistics strategies in pharma?
There is a significant effect on raw material sourcing, logistics, methods, and multi-tier management.
Q4. What changes are you seeing in the role of information systems and digital platforms within pharmaceutical operations management?
AI/ML-integrated systems with big data acquisition and analytics are helping mitigate chaotic, hectic supply chains.
Q5. What emerging disruptions do you believe could most significantly reshape pharmaceutical operations and global…
Create an account to continue reading
Create AccountAlready have an account? Sign in
Need an expert in this space?
Talk to an Industry Expert
Knowledge Ridge connects decision-makers with carefully vetted subject matter experts for one-on-one calls, research sprints, and advisory engagements — across 11 sectors and 163 sub-industries globally.
Comments
No comments yet. Be the first to comment!